Validation of the MENQOL for use with women who have been treated for gynecologic or breast cancer

Catherine Dolye, Lauran Adams, Alison McAndrew, Stephanie Burlein-Hall, Tracey DasGupta, Jennie Blake, Margaret I. Fitch

Abstract


Purpose: To conduct a psychometric evaluation of the MENQOL, a condition-specific, self-report instrument to assess menopausal symptoms in women with gynecologic and breast cancers.

Methods: Identify face and content validity of the MENQOL with experts, and reliability and construct validity with a group of women diagnosed with cancer who are suffering from treatment-induced menopause.

Results: Eighty-two women with treatment-induced menopause completed the MENQOL, EORTC-C30, and the SVQ. The MENQOL was shown to have good face and content validity, and acceptable reliability (homogeneity and test-retest) and validity (concurrent and construct). Additionally, 85.5% of the women reported experiencing hot flashes. However, the most bothersome symptoms were weight gain and fatigue (feeling worn out).

Implications: The MENQOL can be used to assess treatment-induced menopausal symptoms in women diagnosed with breast or gynecologic cancer. 


Full Text:

PDF

References


Aaronson, N.K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N.J. et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality of life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376.

Abbott-Anderson, K., & Kwekkeboom, K.L. (2012). A systematic review of sexual concerns reported by gynecological cancer survivors. Gynecologic Oncology, 124(3), 477–489. http://doi.org/10.1016/j.ygyno.2011.11.030

Cebeci, F., Yangin, H.B., & Tekeli, A. (2010). Determination of changes in the sexual lives of young women receiving breast cancer treatment: A qualitative study. Sexuality and Disability, 28(4), 255–264. http://doi.org/10.1007/s11195-010-9169-1

Davis, C., Zinkand, J., & Fitch, M.I. (2000). Cancer treatment induced menopause: Meaning for breast and gynecological cancer survivors. Canadian Oncology Nursing Journal, 10(1), 14–21.

Feldman, J.E. (1989). Ovarian failure and cancer treatment: incidence and interventions for the premenopausal woman. Oncology Nursing Forum, 16, 651–657.

Fitch, M. (2000). Supportive care for cancer patients. Hospital Quarterly, 3(4), 39–44.

Hilditch, J.R., Lewis, J., Peter, A. van Maris, B., Ross, A., Franssen, E. et al. (1996). A menopause-specific quality of life questionnaire: Development and psychometric properties. Maturitas, 24, 161–175.

Howell, D., Fitch, M.I., & Deane, K.A. (2003). Women’s experiences with recurrent ovarian cancer. Cancer Nursing, 26(1), 10–17.

Jensen, P.T., Klee, M.C., Thranov, I., & Groenvold, M. (2004). Validation of a questionnaire for self-assessment of sexual function and vaginal changes after gynecologic cancer. Psycho-oncology, 13, 577–592.

MacDonald, P. (2007). Update on treatment for breast cancer. Practice Nurse, 33(3), 39–41.

North American Menopause Society (NAMS). Menopause practice: A clinican’s guide (3rd ed.). Cleveland, OH: Author.

Nunnally, J.C. (2006). Psychometric Theory. New York: McGraw-Hill.

Radtke, J.V., Terhorst, L., & Cohen, S.M. (2011). The Menopause Specific Quality of Life (MENQOL) Questionnaire: Psychometric evaluation among breast cancer survivors. Menopause, 18(3), 289–295. doi:10.1097/qme.Ob013e3181ef975a

Society of Obstretrics and Gynecologists of Canada. (2006). Canadian consensus conference on menopause update. Journal of Obstetrics and Gynecoloy Canada, 28(Special Edition), s7–s27.


Refbacks

  • There are currently no refbacks.


Bookmark and Share